An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

EARLY data from the respiratory syncytial virus (RSV) vaccination programme shows it is reducing hospital admissions for older people. The UK Health Security Agency (UKHSA) analysis indicates 30 per ...

Risk factors for RSV transmission included index case viral detection 1 week or more after an index case and a household contact age of 12 years or younger. Of 120 sequenced specimens, the main ...

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

The United Kingdom’s Health Security Agency (HSA) yesterday published it first annual report on infectious disease trends, ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

Kelly Osbourne has opened up about a health scare that saw her hooked up to an assisted breathing machine. The 40-year-old, ...